Sep 28, 2020
554:549
For every 549 shares held, investors received 554. The price per share adjusted from $27.45 to $27.20.
The split itself did not change the total investment value.
Taiwan Advance Bio-Pharmaceutical, Inc. (TPEX:4186) operates in the Medical specialties industry.
Taiwan Advance Bio-Pharmaceutical, Inc. company overviewTaiwan Advance Bio-Pharmaceutical, Inc.'s most recent stock split was on September 28, 2020. It was a 554-for-549 forward split, so shareholders received 554 shares for every 549 they held.
Taiwan Advance Bio-Pharmaceutical, Inc. (TPEX:4186) has split its stock 3 times: a 935-for-926 split on April 28, 2016, a 921-for-914 split on April 27, 2018, and a 554-for-549 split on September 28, 2020.
Taiwan Advance Bio-Pharmaceutical, Inc. has split its stock 3 times. This history records 3 forward splits between April 28, 2016 and September 28, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Taiwan Advance Bio-Pharmaceutical, Inc.'s 554-for-549 split on September 28, 2020, every 549 shares became 554 shares.
Taiwan Advance Bio-Pharmaceutical, Inc. has not announced a new split in our records. Its most recent split was on September 28, 2020, 6 years ago. Companies announce splits in advance, and any new TPEX:4186 split will appear on this page.
Already premium?